EnteroMedics has positioned its technology as an alternative to bariatric surgery. The company's treatment will cost in the low to mid $20,000 range, compared to the upper $20,000 range for surgery, Knudson said. He said the device also is safer than surgery, which should appeal to insurance companies. The company is now in discussions with insurers about covering Maestro.